AMSIDINE

This brand name is authorized in Estonia, Ireland, Netherlands, United Kingdom

Active ingredients

The drug AMSIDINE contains one active pharmaceutical ingredient (API):

1 Acridinyl Anisidide
UNII 00DPD30SOY - AMSACRINE

Amsidine is a sterile antitumour chemotherapeutic agent for intravenous infusion. Although not completely clarified, the mode of action of amsacrine is related to its property of binding the DNA through intercalation and external (electrostatic) forces.

Read about Acridinyl Anisidide

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
AMSIDINE 50mg/ml Concentrate and solvent for solution for infusion Health Products Regulatory Authority (IE) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
L01XX01 Amsacrine L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01X Other antineoplastic agents → L01XX Other antineoplastic agents
Discover more medicines within L01XX01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: EE Ravimiamet Identifier(s): 1880490
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 244039
Country: NL Z-Index G-Standaard Identifier(s): 13717782
Country: NL Z-Index G-Standaard, PRK Identifier(s): 135941

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.